Found 5 matching trials
Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia
PHASE1The purpose of this study is to evaluate the safety and efficacy of chimeri...
Location
Guangdong General Hospital
A Multicenter Study of CAR-T Cells in Primary Ph+All
PHASE2A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients ...
Location
The first affiliated hospital of medical college of zhejiang university
CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
PHASE2Chimeric antigen receptor T cells (CAR-T cells) has been recognized a promi...
Location
Nanfang Hospital, Southern Medical University
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
PHASE1The purpose of this research is to evaluate if study therapy, 19(T2)28z1xx ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
PHASE1The purpose of this study is to test the safety of 19(T2)28z1xx CAR T cells...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)